Research for the human needs of tomorrow

Eurodrug Laboratories is an international pharmaceutical company that enables healthcare professionals and their patients to have access to high quality pharmaceutical products.

250

Registered trademarks

3

Original
product patents

7

Original compounds

12

Innovative delivery systems & novel formulations

Develop, register, manufacture and market high quality pharmaceutical products, medical devices and OTC products

Develop, register, manufacture and market high quality pharmaceutical products, medical devices and OTC products

Market our products through Eurodrug’s dedicated field forces and local licensees

Market our products through Eurodrug’s dedicated field forces and local licensees

Strengthen the strategic research alliances in all our current Key Therapeutic Segments.

Strengthen the strategic research alliances in all our current Key Therapeutic Segments.

EXPLORING FOR A BETTER FUTURE

At Eurodrug we provide high quality, innovative and branded generic pharmaceutical products from European R&D and across wide range of therapeutic areas

We are active across different regions, constantly striving for excellence in healthcare and looking for new collaborations.

Hong Kong, India, Indonesia, Korea, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand, Vietnam, Cambodia

Argentina, Bolivia, Chile, Colombia, Dominican Republic, Ecuador, Mexico

Armenia, Azerbaijan. Georgia, Hungary, Turkmenistan, Moldova, Ukraine, Uzbekistan

Spain, Portugal, Greece, Romania

South Africa

Our respiratory line contains state of the art medicinal products for the treatment of different types of respiratory diseases.

Products in this therapeutic area are aimed at restoring and maintaining gastrointestinal health.

We offer a variety of safe and effective products to assure the younger generation gets the best possible treatment.

We present a variety of products for women in nearly every stage of their lives from adolescent to post-menopausal women.

Our pain management portfolio contains several nimesulide-based products that are known for their fast onset of action.

EELCO BROERSMA

Started his career in 1993 as an auditor at De Keijzer, Nipius & Co (now Crowe), serving many clients in the Life Sciences Industries as Account and Audit Manager untill 2001. He holds a degree in Business Economics from the University of Amsterdam.

Mr. Eelco Broersma became Chief Executive Officer of Eurodrug Laboratories in August 2017 after the acquisition of Eurodrug by Pacific Healthcare (Thailand). From January 2008 till July 2017, he has served as Chief Financial Officer while simultaneously overseeing the Supply Chain and Human Resources departments.